Search filters

List of works by Yasaman Taslimi

A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers.

scientific article

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy

scientific article published on 25 March 2016

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites

scientific article published on 14 July 2017

DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica

scientific article published on 11 January 2019

EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.

scientific article published on 19 December 2015

Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae

scientific article published on 26 March 2011

Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen

scientific article (publication date: March 2014)

Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies

scientific article published on 25 December 2010

Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.

scientific article published in May 2004

Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice

scientific article

Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients

scientific article

Leishmaniasis and various immunotherapeutic approaches.

scientific article published on 15 December 2016

Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.

scientific article published in May 2005

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.

scientific article published on November 2012

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

scientific article published on 8 October 2009

Retracted: Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis

retracted article

The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica

scientific article published on 07 January 2020

Type I signal peptidase from Leishmania is a target of the immune response in human cutaneous and visceral leishmaniasis

scientific article published on May 2004

Paulina is supported by:

About Paulina

Help